Abacus dx NZSO 2025
Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.
Abacus dx NZSO 2025 Showcase
Abacus dx creates value by connecting innovative global suppliers with Australasian customers. We proudly partner with leading suppliers to meet our customers’ complex demands.
Visit our team and discover more about our extensive range of specialised solutions at our booth.
Asuragen
Asuragen’s molecular assays are designed to provide streamlined workflow and ease of use and is comprised of two product portfolios; Genetics and Oncology. The genetics portfolio includes assays aiding in the detection of the FMR1 and C9orf72 gene, while the Oncology assays use molecular methods ranging from qPCR to NGS to assist our understanding of cancer.
Biocartis
Biocartis provides fully integrated and broadly applicable molecular diagnostics. The Idylla is Biocartis’ fully automated, real-time PCR-based molecular diagnostics system which provides fast access to highly reliable clinical molecular diagnostic information. The Idylla can detect BRAF V600E, E2, D, K, R and M mutations within 90 minutes.
ZytoVision
ZytoVision develop and produce innovative in vitro diagnostic products, primarily for tumour diagnosis, based on the technique of in situ hybridization using FISH and CISH techniques.